Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chia Siang Kow, Kaeshaelya Thiruchelvam & Syed Shahzad Hasan. (2020) Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Review of Cardiovascular Therapy 18:8, pages 475-485.
Read now
Read now
Articles from other publishers (14)
Natalia A. Bebyakova, Sergey Levitsky, Irina A. Shabalina, Tatyana Mikhailovna Komandresova & Alexander V. Kudryavtsev. (2023) RENIN-ANGIOTENSIN SYSTEM GENE POLYMORPHISM AND AGING. Ekologiya cheloveka (Human Ecology).
Crossref
Crossref
Sarfaraz Ahmad & Carlos M. Ferrario. 2023. The Renin Angiotensin System in Cardiovascular Disease. The Renin Angiotensin System in Cardiovascular Disease
159
172
.
Mohammadarian Akbari, Reyhane Eghtedarian, Bashdar Mahmud Hussen, Solat Eslami, Mohammad Taheri & Soudeh Ghafouri-Fard. (2022) Angiotensin I converting enzyme gene polymorphisms and risk of psychiatric disorders. BMC Psychiatry 22:1.
Crossref
Crossref
Wang Li & Dong Changwu. (2022) A homozygote for rs12709426 of the ACE gene in patients with essential hypertension: a case report. A homozygote for rs12709426 of the ACE gene in patients with essential hypertension: a case report.
Y. R. Timasheva, K. A. Gerasimova, I. A. Tuktarova, V. V. Erdman & T. R. Nasibullin. (2022) Polygenic analysis of genetic susceptibility to essential hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 28:1, pages 33-45.
Crossref
Crossref
Martina Chiriacò, Domenico TricòSimone Leonetti, John R. PetrieBeverley BalkauKurt HøjlundZoltan PatakyPeter M Nilsson, Andrea NataliR.J. Heine, J. Dekker, S. de Rooij, G. Nijpels, W. Boorsma, A. Mitrakou, S. Tournis, K. Kyriakopoulou, P. Thomakos, N. Lalic, K. Lalic, A. Jotic, L. Lukic, M. Civcic, J. Nolan, T.P. Yeow, M. Murphy, C. DeLong, G. Neary, M.P. Colgan, M. Hatunic, T. Konrad, H. Böhles, S. Fuellert, F. Baer, H. Zuchhold, A. Golay, E. Harsch Bobbioni, V. Barthassat, V. Makoundou, T.N.O. Lehmann, T. Merminod, C. Perry, F. Neary, C. MacDougall, K. Shields, L. Malcolm, M. Laakso, U. Salmenniemi, A. Aura, R. Raisanen, U. Ruotsalainen, T. Sistonen, M. Laitinen, H. Saloranta, S.W. Coppack, N. McIntosh, J. Ross, L. Pettersson, P. Khadobaksh, M. Laville, F. Bonnet, A. Brac de la Perriere, C. Louche-Pelissier, C. Maitrepierre, J. Peyrat, S. Beltran, A. Serusclat, R. Gabriel, E.M. Sánchez, R. Carraro, A. Friera, B. Novella, P. Nilsson, M. Persson, G. Östling, O. Melander, P. Burri, P.M. Piatti, L.D. Monti, E. Setola, E. Galluccio, F. Minicucci, A. Colleluori, M. Walker, I.M. Ibrahim, M. Jayapaul, D. Carman, C. Ryan, K. Short, Y. McGrady, D. Richardson, H. Beck-Nielsen, P. Staehr, V. Vestergaard, C. Olsen, L. Hansen, G.B. Bolli, F. Porcellati, C. Fanelli, P. Lucidi, F. Calcinaro, A. Saturni, E. Ferrannini, E. Muscelli, S. Pinnola, M. Kozakova, A. Casolaro, B.D. Astiarraga, G. Mingrone, C. Guidone, A. Favuzzi, P. Di Rocco, C. Anderwald, M. Bischof, M. Promintzer, M. Krebs, M. Mandl, A. Hofer, A. Luger, W. Waldhäusl, M. Roden, F. Bonnet, S.W. Coppack, J.M. Dekker, E. Ferrannini, A. Mari, J. Petrie, M. Walker, P. Gaffney, J. Nolan, G. Boran, C. Olsen, L. Hansen, H. Beck-Nielsen, A. Kok, J. Dekker, S. Patel, M. Walker, A. Gastaldelli, D. Ciociaro, M. Kozakova, M.T. Guillanneuf, L. Mhamdi, A. Mari, L. Mhamdi, L. Landucci, S. Hills, L. Mota, A. Mari, G. Pacini, C. Cavaggion, A. Tura, S.A. Hills, L. Landucci & L. Mota. (2022) Female Sex and Angiotensin-Converting Enzyme (ACE) Insertion/Deletion Polymorphism Amplify the Effects of Adiposity on Blood Pressure. Hypertension 79:1, pages 36-46.
Crossref
Crossref
Lei Fang, Liang Zhou, Michael Tamm & Michael Roth. (2021) OM-85 Broncho-Vaxom®, a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells. Biomedicines 9:11, pages 1544.
Crossref
Crossref
Murat Oz, Dietrich Ernst Lorke & Nadine Kabbani. (2021) A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor. Pharmacology & Therapeutics 221, pages 107750.
Crossref
Crossref
A. A. Akopyan, I. D. Strazhesko, O. N. Tkacheva, A. P. Yesakova & I. A. Orlova. (2021) Review of polymorphisms, associated with cardiovascular diseases. Russian Journal of Geriatric Medicine:4, pages 333-338.
Crossref
Crossref
Hamideh Amirfakhryan & Fatemeh safari. (2021) Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement. Hellenic Journal of Cardiology 62:1, pages 13-23.
Crossref
Crossref
Venkatesh Pooladanda, Sowjanya Thatikonda & Chandraiah Godugu. (2020) The current understanding and potential therapeutic options to combat COVID-19. Life Sciences 254, pages 117765.
Crossref
Crossref
Chia Siang Kow, Syed Tabish Razi Zaidi & Syed Shahzad Hasan. (2020) Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. American Journal of Cardiovascular Drugs 20:3, pages 217-221.
Crossref
Crossref
Lei Fang, George Karakiulakis & Michael Roth. (2020) Antihypertensive drugs and risk of COVID-19? – Authors' reply. The Lancet Respiratory Medicine 8:5, pages e32-e33.
Crossref
Crossref
Sarper YILMAZ, Nazif ELALDI & Hakan ERTIN. (2020) An ongoing debate: Are the patients receiving angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers more susceptible to COVID-19 ?Süregelen Bir Tartışma: Anjiotensin-Konverting Enzim İnhibitörü ve/veya Anjiotensin Reseptör Blokörü Kullanan Hastaların COVID-19’a Karşı Duyarlılığı Daha Fazla mıdır?. Anadolu Kliniği Tıp Bilimleri Dergisi 25:Special Issue on COVID 19, pages 79-84.
Crossref
Crossref